ras Gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions

William Andrew Yeudall, L. K. Torrance, K. A. Elsegood, P. Speight, C. Scully, S. S. Prime

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Three series of biopsy specimens of premalignant and malignant oral lesions, together with seven human keratinocyte cultures, previously established from oral squamous cell carcinomas, were analysed for point mutation in exons 1 and 2 of the c-Ha-ras, c-Ki-ras and N-ras genes by direct nucleotide sequencing of DNAs amplified in the polymerase chain reaction (PCR). Only one out of 12 biopsy samples (8.3%), a well-differentiated carcinoma which was the latest in a series of floor of mouth lesions from 1 of the 3 patients studied, harboured a mutant c-Ha-ras gene, being heterozygous at codon 12 for a GGA-GTA change. One cell line (H357) showed heterozygosity in both exons 1 and 2 of c-Ha-ras, harbouring a GGT to AGT mutation over codon 13 and a CAG to CAA mutation over codon 61. The remaining six oral carcinoma cell lines (85.7%) were homozygous normal at both exons 1 and 2 of c-Ha-ras. All cell lines showed normal c-Ki-ras and N-ras loci. We conclude that ras gene mutation is an infrequent occurrence in the malignant progression of oral epithelial cells, despite the probable importance of chemical carcinogens in the aetiology of the disease. We emphasise the need to search for other cellular sequences which may be targets for chemical or viral carcinogens.

Original languageEnglish (US)
Pages (from-to)63-67
Number of pages5
JournalEuropean Journal of Cancer. Part B: Oral Oncology
Volume29
Issue number1
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

ras Genes
Point Mutation
Codon
Exons
Mucous Membrane
Cell Line
Carcinogens
Mutation
Carcinoma
Biopsy
Mouth Floor
DNA Sequence Analysis
Keratinocytes
Squamous Cell Carcinoma
Nucleotides
Epithelial Cells
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

ras Gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions. / Yeudall, William Andrew; Torrance, L. K.; Elsegood, K. A.; Speight, P.; Scully, C.; Prime, S. S.

In: European Journal of Cancer. Part B: Oral Oncology, Vol. 29, No. 1, 01.01.1993, p. 63-67.

Research output: Contribution to journalArticle

@article{7439a15110604855970baaa79bb4ae3d,
title = "ras Gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions",
abstract = "Three series of biopsy specimens of premalignant and malignant oral lesions, together with seven human keratinocyte cultures, previously established from oral squamous cell carcinomas, were analysed for point mutation in exons 1 and 2 of the c-Ha-ras, c-Ki-ras and N-ras genes by direct nucleotide sequencing of DNAs amplified in the polymerase chain reaction (PCR). Only one out of 12 biopsy samples (8.3{\%}), a well-differentiated carcinoma which was the latest in a series of floor of mouth lesions from 1 of the 3 patients studied, harboured a mutant c-Ha-ras gene, being heterozygous at codon 12 for a GGA-GTA change. One cell line (H357) showed heterozygosity in both exons 1 and 2 of c-Ha-ras, harbouring a GGT to AGT mutation over codon 13 and a CAG to CAA mutation over codon 61. The remaining six oral carcinoma cell lines (85.7{\%}) were homozygous normal at both exons 1 and 2 of c-Ha-ras. All cell lines showed normal c-Ki-ras and N-ras loci. We conclude that ras gene mutation is an infrequent occurrence in the malignant progression of oral epithelial cells, despite the probable importance of chemical carcinogens in the aetiology of the disease. We emphasise the need to search for other cellular sequences which may be targets for chemical or viral carcinogens.",
author = "Yeudall, {William Andrew} and Torrance, {L. K.} and Elsegood, {K. A.} and P. Speight and C. Scully and Prime, {S. S.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1016/0964-1955(93)90012-4",
language = "English (US)",
volume = "29",
pages = "63--67",
journal = "European Journal of Cancer Part B: Oral Oncology",
issn = "0964-1955",
publisher = "Pergamon Press Ltd.",
number = "1",

}

TY - JOUR

T1 - ras Gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions

AU - Yeudall, William Andrew

AU - Torrance, L. K.

AU - Elsegood, K. A.

AU - Speight, P.

AU - Scully, C.

AU - Prime, S. S.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Three series of biopsy specimens of premalignant and malignant oral lesions, together with seven human keratinocyte cultures, previously established from oral squamous cell carcinomas, were analysed for point mutation in exons 1 and 2 of the c-Ha-ras, c-Ki-ras and N-ras genes by direct nucleotide sequencing of DNAs amplified in the polymerase chain reaction (PCR). Only one out of 12 biopsy samples (8.3%), a well-differentiated carcinoma which was the latest in a series of floor of mouth lesions from 1 of the 3 patients studied, harboured a mutant c-Ha-ras gene, being heterozygous at codon 12 for a GGA-GTA change. One cell line (H357) showed heterozygosity in both exons 1 and 2 of c-Ha-ras, harbouring a GGT to AGT mutation over codon 13 and a CAG to CAA mutation over codon 61. The remaining six oral carcinoma cell lines (85.7%) were homozygous normal at both exons 1 and 2 of c-Ha-ras. All cell lines showed normal c-Ki-ras and N-ras loci. We conclude that ras gene mutation is an infrequent occurrence in the malignant progression of oral epithelial cells, despite the probable importance of chemical carcinogens in the aetiology of the disease. We emphasise the need to search for other cellular sequences which may be targets for chemical or viral carcinogens.

AB - Three series of biopsy specimens of premalignant and malignant oral lesions, together with seven human keratinocyte cultures, previously established from oral squamous cell carcinomas, were analysed for point mutation in exons 1 and 2 of the c-Ha-ras, c-Ki-ras and N-ras genes by direct nucleotide sequencing of DNAs amplified in the polymerase chain reaction (PCR). Only one out of 12 biopsy samples (8.3%), a well-differentiated carcinoma which was the latest in a series of floor of mouth lesions from 1 of the 3 patients studied, harboured a mutant c-Ha-ras gene, being heterozygous at codon 12 for a GGA-GTA change. One cell line (H357) showed heterozygosity in both exons 1 and 2 of c-Ha-ras, harbouring a GGT to AGT mutation over codon 13 and a CAG to CAA mutation over codon 61. The remaining six oral carcinoma cell lines (85.7%) were homozygous normal at both exons 1 and 2 of c-Ha-ras. All cell lines showed normal c-Ki-ras and N-ras loci. We conclude that ras gene mutation is an infrequent occurrence in the malignant progression of oral epithelial cells, despite the probable importance of chemical carcinogens in the aetiology of the disease. We emphasise the need to search for other cellular sequences which may be targets for chemical or viral carcinogens.

UR - http://www.scopus.com/inward/record.url?scp=0027474504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027474504&partnerID=8YFLogxK

U2 - 10.1016/0964-1955(93)90012-4

DO - 10.1016/0964-1955(93)90012-4

M3 - Article

VL - 29

SP - 63

EP - 67

JO - European Journal of Cancer Part B: Oral Oncology

JF - European Journal of Cancer Part B: Oral Oncology

SN - 0964-1955

IS - 1

ER -